Download PDF
Semin Liver Dis 2002; 22(4): 325-338
DOI: 10.1055/s-2002-35703
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Animal Models of Autoimmune Hepatitis

Elmar Jaeckel
  • Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts
Further Information

Publication History

Publication Date:
25 November 2002 (online)

    Permissions and Reprints

ABSTRACT

Autoimmune hepatitis (AIH) is difficult to study in humans because of the late diagnosis, the heterogenic genetic background and the lack of tissue specimens. Therefore, animal models have been used for more than 90 years to study liver-specific immune regulation. This article summarizes how early studies of experimental AIH established the importance of T cells for causing the liver injury and how regulatory pathways were detected. Studies in transgenic models demonstrated that T cells can be tolerant to liver antigens by ignorance, deletion, anergy, and receptor downregulation. They furthermore defined functions in antigen presentation for hepatocytes and sinusoidal endothelial cells. Studies in cytokine-induced models show common effector cascades resulting from T-cell activation and the interaction of innate and adaptive immune response. The use of animal models of AIH will improve our understanding of the pathophysiology of the disease and might help to explore new possibilities for therapy and prevention.

KEYWORDS

Experimental autoimmune hepatitis - tolerance - anergy - deletion - immune regulation - cytokines - regulatory cells

REFERENCES

  • 1 Vyse T J, Todd J A. Genetic analysis of autoimmune disease.  Cell . 1996;  85 311-318
    CrossrefPubMedGoogle Scholar
  • 2 Encinas J A, Wicker L S, Peterson L B. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2.  Nat Genet . 1999;  21 158-160
    PubMedGoogle Scholar
  • 3 Vafiadis P, Bennett S T, Todd J A. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.  Nat Genet . 1997;  15 289-292
    CrossrefPubMedGoogle Scholar
  • 4 Pugliese A, Zeller M, Fernandez Jr A. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.  Nat Genet . 1997;  15 293-297
    CrossrefPubMedGoogle Scholar
  • 5 Waldenstroem J. Leber, Blutproteine, Nahrungseiweisse.  Dtsch Gesellschaft fuer Verdauung und Stoffwechsel . 1950;  15 113-119
    PubMedGoogle Scholar
  • 6 Fiessinger N, ed. Histogenèse des processus de cirrhose hépatique. Lésion parenchymateuse et cirrhose. Paris: 1908
    Google Scholar
  • 7 Casals J, Olitsky P K. Tests for hepatic dysfunction in mice.  Proc Soc Exp Biol . 1946;  63 383-389
    PubMedGoogle Scholar
  • 8 Behar A J, Tal C. Experimental liver necrosis produced by injection of homologous whole liver with adjuvant.  J Pathol Bacteriol . 1959;  77 591-596
    CrossrefPubMedGoogle Scholar
  • 9 Matzinger P. An innate sense of danger.  Ann NY Acad Sci . 2002;  961 341-342
    PubMedGoogle Scholar
  • 10 Matzinger P. Tolerance, danger, and the extended family.  Annu Rev Immunol . 1994;  12 991-1045
    CrossrefPubMedGoogle Scholar
  • 11 Dodd M C, Bigley N J, Geyer V B. Autoimmune response in rabbits injected with rat liver ribosomes.  Science . 1962;  137 688-689
    PubMedGoogle Scholar
  • 12 Warnatz H, Scheiffarth F, Schwarz R. Animal experiment studies on the pathogenesis of chronic hepatitis. II. Serological studies following sensitization with homologous liver cell fractions.  Virchows Arch Pathol Anat Physiol Klin Med . 1965;  339 364-371
    PubMedGoogle Scholar
  • 13 Scheiffarth F, Warnatz H, Niederer W. Tierexperimentelle Studien zur Pathogenese der chronischen Hepatitis. I. Mitteilung. Morphologische Studien an der Leber nach Sensibilisierung mit homologen Leberzellfraktionen.  Virchows Arch A Pathol Anat Histol . 1965;  339 358-365
    PubMedGoogle Scholar
  • 14 Wies I, Brunner S, Henninger J. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.  Lancet . 2000;  355 1510-1515
    CrossrefPubMedGoogle Scholar
  • 15 Costa M, Rodriguez-Sanchez J L, Czaja A J. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis.  Clin Exp Immunol . 2000;  121 364-374
    CrossrefPubMedGoogle Scholar
  • 16 Volkmann M, Martin L, Baurle A. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.  Hepatology . 2001;  33 591-596
    CrossrefPubMedGoogle Scholar
  • 17 Meyer zum Buschenfelde H K, Kössling F K, Miescher P A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.  Clin Exp Immunol . 1972;  10 99-108
    PubMedGoogle Scholar
  • 18 McFarlane I G, Wojcicka B M, Zucker G M. Purification and characterization of human liver-specific membrane lipoprotein (LSP).  Clin Exp Immunol . 1977;  27 381-390
    PubMedGoogle Scholar
  • 19 Kössling F K, Meyer zum Büschenfelde K H. Zur Induktion einer aktiven chronischen Hepatitis durch heterologe Leberproteine.  Virchows Arch A Pathol Anat Histol . 1968;  345 365-376
    PubMedGoogle Scholar
  • 20 Meyer zum Buschenfelde H K, Hopf U. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.  Br J Exp Pathol . 1974;  55 498-508
    PubMedGoogle Scholar
  • 21 Hopf U, Meyer zum Buschenfelde H K, Hutteroth T. Humoral immune reactions on the hepatocellular plasma membrane in the experimental chronic active hepatitis in rabbits [in German].  Klin Wochenschr . 1976;  54 591-598
    CrossrefPubMedGoogle Scholar
  • 22 Hopf U, Meyer zum Buschenfelde H K. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes.  Br J Exp Pathol . 1974;  55 509-513
    PubMedGoogle Scholar
  • 23 Feighery C, McDonald G S, Greally J F. Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.  Clin Exp Immunol . 1981;  45 143-151
    PubMedGoogle Scholar
  • 24 Uibo R M, Helin H J, Krohn K J. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.  Clin Exp Immunol . 1982;  48 505-512
    PubMedGoogle Scholar
  • 25 Feighery C, Weir D G. How specific is liver-specific protein?.  Gastroenterology . 1980;  79 179-180
    PubMedGoogle Scholar
  • 26 Scheiffarth F, Warnatz H, Mayer K. Studies concerning the importance of mononuclear cells in the development of experimental hepatitis.  J Immunol . 1967;  98 396-401
    PubMedGoogle Scholar
  • 27 Warnatz H, Scheiffarth F, Schmeissner R. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.  Clin Exp Immunol . 1975;  21 250-258
    PubMedGoogle Scholar
  • 28 Kuriki J, Murakami H, Kakumu S. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae.  Gastroenterology . 1983;  84 596-603
    PubMedGoogle Scholar
  • 29 Mori Y, Mori T, Yoshida H. Study of cellular immunity in experimental autoimmune hepatitis in mice.  Clin Exp Immunol . 1984;  57 85-92
    PubMedGoogle Scholar
  • 30 Mori Y, Mori T, Ueda S. Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.  Clin Exp Immunol . 1985;  61 577-584
    PubMedGoogle Scholar
  • 31 Mori T, Mori Y, Yoshida H. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells-in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis.  Hepatology . 1985;  5 770-777
    PubMedGoogle Scholar
  • 32 Araki K, Yamamoto H, Fujimoto S. Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction.  Clin Exp Immunol . 1987;  67 326-334
    PubMedGoogle Scholar
  • 33 Bartholomaeus W N, O'Donoghue H, Reed W D. Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse.  Clin Exp Immunol . 1984;  55 541-545
    PubMedGoogle Scholar
  • 34 Watanabe Y, Kawakami H, Kawamoto H. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.  Clin Exp Immunol . 1987;  67 105-113
    PubMedGoogle Scholar
  • 35 Asano M, Toda M, Sakaguchi N. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.  J Exp Med . 1996;  184 387-396
    CrossrefPubMedGoogle Scholar
  • 36 Shevach E M. CD4+ CD25+ suppressor T cells: more questions than answers.  Nat Rev Immunol . 2002;  2 389-400
    PubMedGoogle Scholar
  • 37 Lohse A W, Manns M, Dienes H P. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity.  Hepatology . 1990;  11 24-30
    PubMedGoogle Scholar
  • 38 Lohse A W, Brunner S, Kyriatsoulis A. Autoantibodies in experimental autoimmune hepatitis.  J Hepatol . 1992;  14 48-53
    PubMedGoogle Scholar
  • 39 Lohse A W, Meyer zum Buschenfelde H K. Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression.  Clin Exp Immunol . 1993;  94 163-167
    PubMedGoogle Scholar
  • 40 Lohse A W, Kogel M, Meyer zum Buschenfelde H K. Evidence for spontaneous immunosuppression in autoimmune hepatitis.  Hepatology . 1995;  22 381-388
    CrossrefPubMedGoogle Scholar
  • 41 Suri-Payer E, Amar A Z, Thornton A M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.  J Immunol . 1998;  160 1212-1218
    PubMedGoogle Scholar
  • 42 Thornton A M, Shevach E M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.  J Exp Med . 1998;  188 287-296
    CrossrefPubMedGoogle Scholar
  • 43 Lohse A W, Dienes H P, Meyer zum Buschenfelde H K. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.  Hepatology . 1998;  27 1536-1543
    CrossrefPubMedGoogle Scholar
  • 44 Derbinski J, Schulte A, Kyewski B. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.  Nat Immunol . 2001;  2 1032-1039
    CrossrefPubMedGoogle Scholar
  • 45 Klein L, Kyewski B. ``Promiscuous'' expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?.  J Mol Med . 2000;  78 483-494
    CrossrefPubMedGoogle Scholar
  • 46 Klein L, Klein T, Ruther U. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium.  J Exp Med . 1998;  188 5-16
    CrossrefPubMedGoogle Scholar
  • 47 Jones-Youngblood S L, Wieties K, Forman J. Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance.  J Immunol . 1990;  144 1187-1195
    PubMedGoogle Scholar
  • 48 Wieties K, Hammer R E, Jones-Youngblood S. Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation.  Proc Natl Acad Sci U S A . 1990;  87 6604-6608
    PubMedGoogle Scholar
  • 49 Morahan G, Brennan F E, Bhathal P S. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.  Proc Natl Acad Sci U S A . 1989;  86 3782-3786
    PubMedGoogle Scholar
  • 50 Moriyama T, Guilhot S, Klopchin K. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.  Science . 1990;  248 361-364
    PubMedGoogle Scholar
  • 51 Chisari F V, Ferrari C. Hepatitis B virus immunopathogenesis.  Annu Rev Immunol . 1995;  13 29-60
    CrossrefPubMedGoogle Scholar
  • 52 Chisari F V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.  Curr Top Microbiol Immunol . 1996;  206 149-173
    PubMedGoogle Scholar
  • 53 Wirth S, Guidotti L G, Ando K. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.  J Immunol . 1995;  154 2504-2515
    PubMedGoogle Scholar
  • 54 Shimizu Y, Guidotti L G, Fowler P. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.  J Immunol . 1998;  161 4520-4529
    PubMedGoogle Scholar
  • 55 Ando K, Guidotti L G, Wirth S. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.  J Immunol . 1994;  152 3245-3253
    PubMedGoogle Scholar
  • 56 Ando K, Moriyama T, Guidotti L G. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.  J Exp Med . 1993;  178 1541-1554
    CrossrefPubMedGoogle Scholar
  • 57 Ando K, Guidotti L G, Cerny A. CTL access to tissue antigen is restricted in vivo.  J Immunol . 1994;  153 482-488
    PubMedGoogle Scholar
  • 58 Ferber I, Schonrich G, Schenkel J. Levels of peripheral T cell tolerance induced by different doses of tolerogen.  Science . 1994;  263 674-676
    PubMedGoogle Scholar
  • 59 Schonrich G, Kalinke U, Momburg F. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.  Cell . 1991;  65 293-304
    CrossrefPubMedGoogle Scholar
  • 60 Schonrich G, Alferink J, Klevenz A. Tolerance induction as a multi-step process.  Eur J Immunol . 1994;  24 285-293
    PubMedGoogle Scholar
  • 61 Alferink J, Schittek B, Schonrich G. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance.  Int Immunol . 1995;  7 331-336
    PubMedGoogle Scholar
  • 62 Schonrich G, Momburg F, Malissen M. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen.  Int Immunol . 1992;  4 581-590
    PubMedGoogle Scholar
  • 63 Heath W R, Allison J, Hoffmann M W. Autoimmune diabetes as a consequence of locally produced interleukin-2.  Nature . 1992;  359 547-549
    CrossrefPubMedGoogle Scholar
  • 64 Limmer A, Sacher T, Alferink J. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment.  Eur J Immunol . 1998;  28 2395-2406
    CrossrefPubMedGoogle Scholar
  • 65 Bertolino P, Heath W R, Hardy C L. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver.  Eur J Immunol . 1995;  25 1932-1942
    PubMedGoogle Scholar
  • 66 Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire.  Science . 1991;  251 1225-1228
    PubMedGoogle Scholar
  • 67 Bertolino P, Trescol-Biemont M C, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival.  Eur J Immunol . 1998;  28 221-236
    CrossrefPubMedGoogle Scholar
  • 68 Bertolino P, Trescol-Biemont M C, Thomas J. Death by neglect as a deletional mechanism of peripheral tolerance.  Int Immunol . 1999;  11 1225-1238
    CrossrefPubMedGoogle Scholar
  • 69 Huang L, Soldevila G, Leeker M. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo.  Immunity . 1994;  1 741-749
    CrossrefPubMedGoogle Scholar
  • 70 Bertolino P, Bowen D G, McCaughan G W. Antigen-specific primary activation of CD8+ T cells within the liver.  J Immunol . 2001;  166 5430-5438
    PubMedGoogle Scholar
  • 71 Voehringer D, Blaser C, Grawitz A B. Break of T cell ignorance to a viral antigen in the liver induces hepatitis.  J Immunol . 2000;  165 2415-2422
    PubMedGoogle Scholar
  • 72 Oldstone M B, Nerenberg M, Southern P. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.  Cell . 1991;  65 319-331
    CrossrefPubMedGoogle Scholar
  • 73 Ohashi P S, Oehen S, Buerki K. Ablation of ``tolerance'' and induction of diabetes by virus infection in viral antigen transgenic mice.  Cell . 1991;  65 305-317
    CrossrefPubMedGoogle Scholar
  • 74 Limmer A, Ohl J, Kurts C. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance.  Nat Med . 2000;  6 1348-1354
    CrossrefPubMedGoogle Scholar
  • 75 Knolle P A, Schmitt E, Jin S. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward TH1 cells.  Gastroenterology . 1999;  116 1428-1440
    CrossrefPubMedGoogle Scholar
  • 76 Lohse A W, Knolle P A, Bilo K. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells.  Gastroenterology . 1996;  110 1175-1181
    PubMedGoogle Scholar
  • 77 Tiegs G. Experimental hepatitis and role of cytokines.  Acta Gastroenterol Belg . 1997;  60 176-179
    PubMedGoogle Scholar
  • 78 Toyonaga T, Hino O, Sugai S. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.  Proc Natl Acad Sci USA . 1994;  91 614-618
    PubMedGoogle Scholar
  • 79 Hussain M J, Mustafa A, Gallati H. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease.  J Hepatol . 1994;  21 816-821
    CrossrefPubMedGoogle Scholar
  • 80 Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A.  J Clin Invest . 1992;  90 196-203
    CrossrefPubMedGoogle Scholar
  • 81 Kusters S, Gantner F, Kunstle G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.  Gastroenterology . 1996;  111 462-471
    PubMedGoogle Scholar
  • 82 Gantner F, Leist M, Lohse A W. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.  Hepatology . 1995;  21 190-198
    CrossrefPubMedGoogle Scholar
  • 83 Gantner F, Leist M, Kusters S. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release.  Exp Cell Res . 1996;  229 137-146
    CrossrefPubMedGoogle Scholar
  • 84 Knolle P A, Gerken G, Loser E. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice.  Hepatology . 1996;  24 824-829
    PubMedGoogle Scholar
  • 85 Takeda K, Hayakawa Y, Van Kaer L. Critical contribution of liver natural killer T cells to a murine model of hepatitis.  Proc Natl Acad Sci USA . 2000;  97 5498-5503
    CrossrefPubMedGoogle Scholar
  • 86 Gantner F, Leist M, Jilg S. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice.  Gastroenterology . 1995;  109 166-176
    PubMedGoogle Scholar
  • 87 Leist M, Gantner F, Bohlinger I. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest.  J Immunol . 1994;  153 1778-1788
    PubMedGoogle Scholar
  • 88 Kuhn R, Lohler J, Rennick D. Interleukin-10-deficient mice develop chronic enterocolitis.  Cell . 1993;  75 263-274
    CrossrefPubMedGoogle Scholar
  • 89 Shull M M, Ormsby I, Kier A B. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.  Nature . 1992;  359 693-699
    CrossrefPubMedGoogle Scholar
  • 90 Gorham J D, Lin J T, Sung J L. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis.  J Immunol . 2001;  166 6413-6422
    PubMedGoogle Scholar
  • 91 Clemente M G, Obermayer-Straub P, Meloni A. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.  J Clin Endocrinol Metab . 1997;  82 1353-1361
    CrossrefPubMedGoogle Scholar
  • 92 Clemente M G, Meloni A, Obermayer-Straub P. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1.  Gastroenterology . 1998;  114 324-328
    PubMedGoogle Scholar
  • 93 Obermeyer-Straub P, Perheentupa J, Braun S. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.  Gastroenterology . 2001;  121 668-677
    PubMedGoogle Scholar